Login / Signup
Industries
Technology
Energy
Media
Finance
Green Issues
China
All Concepts
Metals
Energy
Meats
Grains
Softs
ETFs
Indices
Currencies
Geographies
Exchanges
Rates
How To Invest
Personal Finance
Options 101
Definitions
close
close
Send us Feedback
Pain Therapeutics (PTIE)
SUMMARY
BULLS
BEARS
DATA CENTRAL
STOCK CHART
BALANCE SHEET
INCOME STMT
CASH FLOW
Key Metrics for PTIE as compared to
Top Competitors
Drug Manufacturers - Other
Pharma & Healthcare
All values TTM unless otherwise noted (*)
INDUSTRY METRICS
No data.
Revenue
Net Income
Operating Income
INCOME STATEMENT (
See all
)
Revenue
►
25.1M
AVG
EBITDA
►
11.1M
HIGH
Net Income
►
-4.56M
AVG
Revenue Growth
►
-63.9%
LOW
Net Income Growth
►
104.2%
AVG
Operating Margin
►
43.4%
HIGH
Net Margin
►
-18.2%
AVG
Revenue, Net Income, and Net Margin
Revenue, Gross Profit, and Gross Margin
Operating Income
Ebit
Income Before Taxes
Net Income from Continuing Ops
Operating Expenses
Research & Development
SG&A
Amortization & Depreciation
BALANCE SHEET (most recent quarter) (
See all
)
Debt / Equity
►
0.723
AVG
Current Ratio
►
9.99
VERY HIGH
Quick Ratio
►
9.99
VERY HIGH
Book Value Per Share
►
2.53
Cash Per Share
►
0.695
Loading...
STOCK SUMMARY
Open
4.87
Day Range
4.99
-
5.10
52 Week Range
3.20
-
9.32
Volume
55K
Avg Volume (3 mo)
219K
Shares Outstanding
42.7M
Market Cap
211M
VALUATION
Price to Earnings (P/E)
►
-45.8
Price to Book (P/B)
►
1.97
AVG
Price to Sales (P/S)
►
8.32
AVG
Return on Assets (ROA)
►
-2.4%
AVG
Return on Equity (ROE)
►
-4.4%
AVG
EV/EBITDA
►
21.4
AVG
Dividend Yield
0%
AVG
ANALYST RECOMMENDATIONS
OWNERSHIP
Net Insider Buying 3mo
-17.9%
Net Insider Buying 6mo
-31.1%
Net Insider Buying 1yr
-38.8%
Held by insiders
34.3%
Held by institutions
39.6%
No Sales Breakout Data.